Literature DB >> 2124096

Association of serum IgM kappa monoclonicity in patients with Sjögren's syndrome with an increased proportion of kappa positive plasma cells infiltrating the labial minor salivary glands.

H M Moutsopoulos1, A G Tzioufas, M K Bai, N M Papadopoulos, C S Papadimitriou.   

Abstract

Minor salivary gland biopsy specimens from 11 patients with primary Sjögren's syndrome with circulating monoclonal IgM kappa cryoglobulins, seven without cryoglobulins, and four patients with rheumatoid arthritis and Sjögren's syndrome (one with monoclonal and three with polyclonal cryoglobulins) were examined by the peroxidase antiperoxidase bridge technique, using antihuman kappa and lambda antibodies. In 6/11 patients with primary Sjögren's syndrome and in one patient with Sjögren's syndrome and rheumatoid arthritis with monoclonal cryoglobulins a predominance of plasma cells containing intracytoplasmic kappa light chains was found (kappa:lambda greater than 3:1). Two of those seven patients had immunohistological features of immunocytomas. In the other five patients with circulating monoclonal cryoglobulins the kappa:lambda ratio of positive cells did not exceed 3:1, while six out of seven patients without cryoglobulins and the patients with rheumatoid arthritis and Sjögren's syndrome with polyclonal cryoglobulins had almost equal numbers of kappa and lambda stained cells. One of seven patients with primary Sjögren's syndrome without cryoglobulins had an increased number of lambda light chain positive cells, indicating a non-secretory lambda monoclonal population. These findings suggest that the main area of B cell monoclonal expansion in primary Sjögren's syndrome may be the affected exocrine glands.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2124096      PMCID: PMC1004265          DOI: 10.1136/ard.49.11.929

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  Minor salivary gland involvement in Sjögren's syndrome.

Authors:  T M Tarpley; L G Anderson; C L White
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1974-01

3.  The unlabeled antibody enzyme method of immunohistochemistry: preparation and properties of soluble antigen-antibody complex (horseradish peroxidase-antihorseradish peroxidase) and its use in identification of spirochetes.

Authors:  L A Sternberger; P H Hardy; J J Cuculis; H G Meyer
Journal:  J Histochem Cytochem       Date:  1970-05       Impact factor: 2.479

4.  Demonstration and identification of monoclonal proteins in the urine of patients with Sjögren's syndrome.

Authors:  H M Moutsopoulos; R Costello; A A Drosos; A K Mavridis; N M Papadopoulos
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

5.  Biologic and clinical significance of cryoglobulins. A report of 86 cases.

Authors:  J C Brouet; J P Clauvel; F Danon; M Klein; M Seligmann
Journal:  Am J Med       Date:  1974-11       Impact factor: 4.965

6.  Salivary gland immunoglobulin and rheumatoid factor synthesis in Sjögren's syndrome. Natural history and response to treatment.

Authors:  L G Anderson; N A Cummings; R Asofsky; M B Hylton; T M Tarpley; T B Tomasi; R O Wolf; G L Schall; N Talal
Journal:  Am J Med       Date:  1972-10       Impact factor: 4.965

7.  Polyclonally triggered B cells in the peripheral blood and bone marrow of normal individuals and in patients with systemic lupus erythematosus and primary Sjögren's syndrome.

Authors:  A S Fauci; H M Moutsopoulos
Journal:  Arthritis Rheum       Date:  1981-04

8.  Natural killing activity in Sjögren's syndrome. An analysis of defective mechanisms.

Authors:  N Miyasaka; W Seaman; A Bakshi; B Sauvezie; V Strand; R Pope; N Talal
Journal:  Arthritis Rheum       Date:  1983-08

9.  Non-IgM monoclonal gammopathy in patients with Sjögren's syndrome.

Authors:  S Sugai; S Konda; Y Shoraski; T Murayama; T Nishikawa
Journal:  Am J Med       Date:  1980-06       Impact factor: 4.965

10.  Presence of intracytoplasmic IgG in the lymphocytic infiltrates of the minor salivary glands of patients with primary Sjögren's syndrome.

Authors:  H C Lane; T R Callihan; E S Jaffe; A S Fauci; H M Moutsopoulos
Journal:  Clin Exp Rheumatol       Date:  1983 Jul-Sep       Impact factor: 4.473

View more
  3 in total

1.  Monotypic plasma cells in labial salivary glands of patients with Sjögren's syndrome: prognosticator for systemic lymphoproliferative disease.

Authors:  C Bodeutsch; P C de Wilde; L Kater; F H van den Hoogen; R J Hené; J C van Houwelingen; L B van de Putte; G P Vooijs
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

Review 2.  Clinical, immunologic, and molecular factors predicting lymphoma development in Sjogren's syndrome patients.

Authors:  Michael Voulgarelis; Fotini N Skopouli
Journal:  Clin Rev Allergy Immunol       Date:  2007-06       Impact factor: 8.667

3.  Sjögren's Syndrome Complicated by Myeloid/Natural Killer Cell Precursor Acute Leukemia: Case Report and Review of the Literature.

Authors:  Hao Feng; Jianlin Qiao; Ningning Ding; Wei Chen; Kunming Qi; Xiuying Pan; Jiang Cao; Kailin Xu
Journal:  Case Rep Hematol       Date:  2016-09-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.